Follow the entities shaping the evidence.

…n progress addressing both primary and secondary prophylaxis of variceal bleeding, with results expected to significantly influence UK best pract…

…ed in year ≥ 2017 according to the DMARD-based regimen (panel A mycophenolate mofetil-based regimens; panel B methotrexate-based regimens; panel C rituxima…

… disease progression and improve long-term outcomes are needed. BMS-986353, a CD19-directed CAR T NEX-T cell therapy, showed early efficac…

…cal phenotype, with the highest levels observed in high-viremic CHD, followed by cirrhosis and low-viremic CHD. Notably, in multiva…

…ing in People with HIV’, conducted in collaboration between the Azienda Ospedaliero-Universitaria Policlinico di Modena and 12 Italian HIV community-based associations.In February 202…

…chronically characterize PLWH. Nevertheless, careful monitoring HIV drug resistance, as well as anthropometric factors such as BMI,…

…ti-TOPO autoantibodies.In the autoimmune prone 129/Sv mice, the rTOPO/CFA injections increased the level of anti-TOPO (p<0.05) and an…

…ery early SSc (VEDOSS), absence of maculopathy, no therapy with Hydroxychloroquine. The OCTA acquisition consisted of 3 x 3 mm scans of the superf…

…giectasia score and clinically relevant outcomes in SSc, namely pulmonary hypertension, interstitial lung disease (ILD), digital ulcers, and mortality…

…Introduction Interstitial lung disease (ILD) is a common and severe complication of systemic sclerosis (SSc)…

…tial DU development to diagnosis, as some developed DU prior to SSc diagnosis. Most participants expressed the need for DU educatio…

…. The mean disease duration was 7.4±6.4 years. All pts received prednisolone at mean dose of 10±4 mg/day. 11% of patients received cyclophos…